Download - Dissolution
![Page 1: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/1.jpg)
DISSOLUTION
Presented by: Muhammed Fahad
![Page 2: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/2.jpg)
DISSOLUTION 2
DISSOLUTIONDefinition:• Dissolution is a process in which a solid substance
solubilizes in a given solvent i.e. mass transfer from the solid surface to the liquid phase.
• Dissolution is the rate determining step for hydrophobic, poorly aqueous soluble drugs.
E.g. Griseofulvin, spironolactone
![Page 3: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/3.jpg)
DISSOLUTION 3
![Page 4: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/4.jpg)
DISSOLUTION 4
Why dissolution studies?
1. To show that the release of drug from the tablet is close to 100%.
2. To show that the rate of drug release is uniform batch to batch.
3. And to show that release is equivalent to those batches proven to be bioavailable and clinically effective.
![Page 5: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/5.jpg)
DISSOLUTION 5
Mechanism of Dissolution
1. Diffusion layer model
2. Danckwert’s model
3. Interfacial barrier model
![Page 6: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/6.jpg)
DISSOLUTION 6
Dissolution mechanisms
2 steps:
1. Interfacial reaction cause liberation of solid particles into boundary layer (Cs).
2. Migration of solute from boundary layer into bulk of solution (C) by diffusion & convection.
• Overall rate of dissolution depends on the slowest step.
• Usually Step (2) is the RDS.
![Page 7: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/7.jpg)
DISSOLUTION 7
Fick’s law:
or
where k = rate constant
![Page 8: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/8.jpg)
DISSOLUTION 8
1. Diffusion Layer Model
• Also called ‘film theory’.• Formation of a thin film at the interface, called as
stagnant layer.• 2 steps are involved:
1) Interaction of solvent with drug surface to form a saturated drug layer , called stagnant layer.
2) Diffusion of drug molecules from stagnant layer into bulk of the system.
![Page 9: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/9.jpg)
DISSOLUTION 9
Diagram Representing Diffusion through the Stagnant Layer
![Page 10: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/10.jpg)
DISSOLUTION 10
Noyes- Whitney’s equation:
dC/dt = dissolution rate of the drug,k = dissolution rate constant,Cs = concentration of drug in the stagnant
layer, andCb = concentration of drug in the bulk of the
solution at time t
![Page 11: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/11.jpg)
DISSOLUTION 11
Modified Noyes-Whitney’s equation:
• Where,• D = diffusion coefficient (diffusivity) of the drug• A = surface area of the dissolving solid• Kw/o = water/oil partition coefficient of the drug.• V = volume of dissolution medium• h = thickness of the stagnant layer• (Cs – Cb)= concentration gradient for diffusion of drug.
![Page 12: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/12.jpg)
DISSOLUTION 12
![Page 13: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/13.jpg)
DISSOLUTION 13
2. Danckwert’s Model • Also called “Penetration or Surface Renewal Theory”.
![Page 14: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/14.jpg)
DISSOLUTION 14
• m = mass of solid dissolved, and• γ = rate of surface renewal (or the interfacial
tension)
![Page 15: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/15.jpg)
DISSOLUTION 15
3. Interfacial Barrier Model• Drug dissolution is a function of solubility rather than
diffusion.• Intermediate concentration exist at the interface as a
result of solvation.• Dissolution rate per unit area, G is given by,
where Ki = effective interfacial transport constant.
![Page 16: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/16.jpg)
DISSOLUTION 16
Powder Dissolution: The Hixson-Crowell Cube Root Law
• Applicable for drug powders of uniform size.• Rate of dissolution based on cube root of wt. of
particles.
M0 = initial mass of powder
M = mass of powder dissolved in time, tk = cube root dissolution rate constant
![Page 17: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/17.jpg)
DISSOLUTION 17
Particulate Dissolution
• Used to study influence of particle size & surface area on dissolution.
• Here, surface area is not made constant.• Weighed powder introduced in dissolution medium
agitated by propeller.• Rate of dissolution increases with decrease in
particle size.• Effective and absolute surface area.
![Page 18: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/18.jpg)
DISSOLUTION 18
PROCESS OF DISSOLUTION
States of matter:• Solid, liquid & gaseous states.• Dissolution involves relocation of a solute molecule
from an environment where it is surrounded by other identical molecules, into a cavity in a liquid.
![Page 19: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/19.jpg)
DISSOLUTION 19
Energy changes:• For spontaneous reactions, ΔG must be –ve.• ‘G’ is a measure of the energy available to a system
to perform work.
ΔG = ΔH – TΔSWhereΔH = change in enthalpy of the systemΔS = change in entropy of the systemT = temperature
• ΔS is usually positive for spontaneous reactions.
![Page 20: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/20.jpg)
DISSOLUTION 20
Intrinsic Dissolution rate
• Rate which is independent of rate of agitation, area
of solute available, etc.
• Intrinsic Dissolution Rate (IDR): rate of mass
transfer per area of dissolving surface.
• It is independent of boundary layer thickness and
volume of slolvent .
![Page 21: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/21.jpg)
DISSOLUTION 21
• Thus,
IDR = k1Cs
• IDR measures the intrinsic properties of the drug
only as a function of the dissolution medium, e.g.
its pH, ionic strength, counter ions, etc.)
![Page 22: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/22.jpg)
DISSOLUTION 22
Measurement of dissolution ratesApparatus Classification in USP:
1. Apparatus 1 (rotating basket)
2. Apparatus 2 (paddle assembly)
3. Apparatus 3 (reciprocating cylinder)
4. Apparatus 4 (flow-through cell)
5. Apparatus 5 (paddle over disk)
6. Apparatus 6 (cylinder)
7. Apparatus 7 (reciprocating holder)
![Page 23: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/23.jpg)
DISSOLUTION 23
Apparatus Classification in European Pharmacopoeia for different dosage forms
![Page 24: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/24.jpg)
DISSOLUTION 24
Problems associated with development of dissolution tests:
1. Need to have a manageable volume of dissolution medium.
2. Development of less-soluble drugs.
3. Insufficient analytical sensitivity for low-dose drugs.
![Page 25: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/25.jpg)
DISSOLUTION 25
According to USP:
A drug product is considered rapidly dissolving when no less than 85% of the labeled amount of the drug substance dissolves within 30 minutes, using USP Apparatus I at 100 rpm (or Apparatus II at 50 rpm) in a volume of 900 ml or less in each of the following media: (1) 0.1 N HCl or Simulated Gastric Fluid USP without enzymes;
(2) a pH 4.5 buffer; and
(3) a pH 6.8 buffer.
![Page 26: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/26.jpg)
DISSOLUTION 26
Biopharmaceutical Classification System
• Class I: High solubility—High permeability• Class II: Low solubility—High permeability• Class III: High solubility—Low permeability• Class IV: Low solubility—Low permeability
![Page 27: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/27.jpg)
DISSOLUTION 27
Measurement of dissolution rates
Beaker method:• Developed by Levy and Hayes.• Consist of 400 ml beaker with 250 ml dissolution
medium.• Medium is agitated by a 3-bladed polyethylene
stirrer of 50 mm diameter.• Stirrer is immersed to a depth of 27 mm into the
dissolution medium and rotated at 60 rpm.
![Page 28: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/28.jpg)
DISSOLUTION 28
Flask-stirrer method:• R.B. flask is used instead of beaker.
Rotating Basket method:• USP Apparatus I• Small wire mesh basket fastened to end of shaft
connected to a motor.• Immersed in a flask maintained at 370C ± 0.50C.• Samples are withdrawn at regular intervals.
![Page 29: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/29.jpg)
DISSOLUTION 29
![Page 30: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/30.jpg)
DISSOLUTION 30
Paddle Assembly method
• USP Apparatus II• Basket in above method is replaced by paddle.• Paddle is continuous with the shaft.• Tablet is placed at the bottom of the medium.
Disadvantages:• Since dissolution volume is limited, use of poorly
soluble drugs is limited.
![Page 31: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/31.jpg)
DISSOLUTION 31
Variables in USP Apparatus I & II
• Type of dissolution medium & its volume.• Type of apparatus to be used.• Speed (rpm) of rotation.• Total time of the test.• Further assay procedures.
![Page 32: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/32.jpg)
DISSOLUTION 32
USP Testing methods:
• 6 tablets monograph tolerance limit, Q + 5%• If fail, 6 more tablets are used avg. of 12 tabs ≥ Q,
and none is < Q-15%.• If failed, 12 more tablets used avg. of 24 tabs ≥ Q,
and no 2 tab is < Q-15% & none is < Q-25%.• Usual tolerance in USP / NF is “not less than 75%
dissolved in 45 min”.
![Page 33: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/33.jpg)
DISSOLUTION 33
![Page 34: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/34.jpg)
DISSOLUTION 34
Reciprocating Cylinder
• Proposed by Beckett & incorporated in USP in 1991.• Mainly used for dissolution testing of extended-
release products.• Also used for poorly soluble drugs.• Capable of agitation and media composition changes
during a run & full automation.• Dips per minute (dpm) is used.• Inner reciprocating tubes & outer tubes.
![Page 35: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/35.jpg)
DISSOLUTION 35Reciprocating Cylinder
![Page 36: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/36.jpg)
DISSOLUTION 36
Use:• Especially useful in the case of chewable tablets.• Studies show that 5 dpm in Apparatus 3 is
equivalent to 50 rpm in Apparatus 2.• So higher dpm can achieve rigorous movts. similar
to chewing—not possible by Apparatus 2.• Used for solutions requiring pH/buffer changes like
enteric-coated/extended-release drugs.
![Page 37: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/37.jpg)
DISSOLUTION 37
Flow-Through Cell
• Introduced by Langenbucher.• Open system—offer unlimited medium supply—
especially useful for poorly soluble drugs.• Also used for dissolution test of sugar-coated tabs,
suppositories, soft gelatin capsules, semi-solids, granules, implants, etc.
• Small volume cell is subjected to continuous stream of dissolution media flow from bottom to top.
![Page 38: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/38.jpg)
DISSOLUTION 38
• Agitation is achieved by pulsating movement of piston.
• Results obtained as fraction dissolved per unit time (due to continuous media flow).
• Data is transformed to the usual cumulative amt. dissolved vs. time.
Advantages:• Maintenance of sink conditions.• Minimizing downtime between tests.
![Page 39: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/39.jpg)
DISSOLUTION 39
Flow-Through Cell
![Page 40: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/40.jpg)
DISSOLUTION 40
Qualification & Validation of the Apparatus
• To maintain “quality by design”.• Physical & chemical calibrations—geometrical &
dimensional accuracy & precision.• Vibration or undesired agitation to be avoided.• Temperature, rotation speed/flow rate, volume,
sampling probe, procedures, etc. need to be monitored periodically.
• Use of USP calibrator tablets for App. 1 & 2 (to be performed not less than twice a year)
![Page 41: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/41.jpg)
DISSOLUTION 41
Factors Affecting Dissolution
Surface area & undissolved solid• Surface area α dissolution.• Coherent masses may reduce total surface area
available overcome by using wetting agent.• Presence of pores.
E.g. dissolution of phenacetin (hydrophobic) is enhanced by adding diluent gelatin (hydrophilic) during granulation.
![Page 42: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/42.jpg)
DISSOLUTION 42
Addition of Tween 80 to dissolution medium (0.1 N HCl) for phenacetin increased the dissolution rate by increasing effective surface area.
![Page 43: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/43.jpg)
DISSOLUTION 43
Solubility of solid in dissolution medium
Temp. of dissolution medium
pH of the medium
Solubility of the drug in dissolution medium
Presence of cosolvents
![Page 44: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/44.jpg)
DISSOLUTION 44
Concentration of solute in solution • Should simulate sink conditions present in GI tract.• Larger volume of dissolution medium helps to
maintain ‘C’ negligible compared to ‘Cs’.
• Removal of dissolved solute from dissolution medium enhances rate of dissolution.
Eg. Adsorption onto another substance Partition to another immiscible liquid Removal of solute by dialysis Cont. replacement of dissolution medium
![Page 45: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/45.jpg)
DISSOLUTION 45
Dissolution rate constant
Depend upon Thickness of boundary layer Degree of agitation Speed of stirring Shape, size & position of stirrer Vol. of dissolution medium Shape & size of container Viscosity of dissolution medium
![Page 46: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/46.jpg)
DISSOLUTION 46
Disintegration & Deaggregation
• Disintegration and subsequent deaggregation may also be RDS for dissolution.o E.g. coated dosage forms
• After disintegration, larger aggregates need to deaggregate to yield fine particles.
![Page 47: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/47.jpg)
DISSOLUTION 47
Effect of manufacturing processes
Addition of lubricants
E.g.: 325-mg salicylic acid dissolved rapidly in 0.1 N HCl when SLS was added to it.
Dissolution rate decreases with addition of hydrophobic lubricants like Mg. stearate.
• Most effective lubricants are hydrophobic act by particle coating hence mfg. process is imp.
![Page 48: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/48.jpg)
DISSOLUTION 48
Addition of disintegrating agents like starch swell & enhance dissolution.
Compression force• Increase in compression force may decrease or
increase dissolution rate.
![Page 49: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/49.jpg)
DISSOLUTION 49
Recent developments in dissolution testing
• Use of more biorelevant media—FaSSIF & FeSSIF media.
• FaSSIF—Fasted State Simulated Intestinal Fluid• FeSSIF—Fed State Simulated Intestinal Fluid
Advantages:• Provide physicochemical properties similar to human
GIT.
![Page 50: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/50.jpg)
DISSOLUTION 50
![Page 51: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/51.jpg)
DISSOLUTION 51
REFERENCE1. Fonner. D. E, Banker. G. S., Granulation & Tablet
Characteristics, In Pharmaceutical Dosage Forms: Tablets. Vol. 2. Edited by H. Lieberman & L. Lachman, Dekker, New York, 1982, p. 202
2. Leon Lachman, Herbert. A. Lieberman, The Theory and Practice of Industrial Pharmacy, 3rd edition, Varghese Publishing House, Bombay, 1991, pp. 301-303
3. Brahmankar. D. M., Sunil Jaiswal. B, Biopharmaceutics and Pharmacokinetics—A Treatise, 1st edition, Vallabh Prakashan, New Delhi, 2006, pp. 19-25
4. Alfred Martin, James Swarbrick, Physical Pharmacy, 3rd edition, Varghese Publishing House, Bombay, 1991, pp. 408-412
![Page 52: Dissolution](https://reader033.vdocuments.us/reader033/viewer/2022061114/5462b893b4af9f531c8b48ff/html5/thumbnails/52.jpg)
DISSOLUTION 52